Yabe Miharu, Yabe Hiromasa
Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine.
Rinsho Ketsueki. 2015 Oct;56(10):1914-21. doi: 10.11406/rinketsu.56.1914.
The inherited bone marrow failure syndromes (IBMFS) are rare disorders in which there is usually some form of bone marrow failure and typical changes in physical appearance, associated with a family history of the same disorder. Patients with IBMFS have a very high risk of developing myelodysplastic syndrome, acute myeloid leukemia, and solid tumors. The latest technology applied to the molecular pathogenesis of these disorders has led to identification of specific genetic mutations and now facilitates determining the appropriate diagnosis and management of afflicted patients. In this section, we describe physical and laboratory findings and management of the major IBMFS: Fanconi anemia, dyskeratosis congenita, Shwachman-Diamond syndrome, and Diamond Blackfan anemia. We also discuss their possible implications in the clinical features of Japanese patients.
遗传性骨髓衰竭综合征(IBMFS)是罕见疾病,通常存在某种形式的骨髓衰竭以及外貌的典型变化,并伴有同一疾病的家族史。患有IBMFS的患者发生骨髓增生异常综合征、急性髓系白血病和实体瘤的风险非常高。应用于这些疾病分子发病机制的最新技术已导致特定基因突变的鉴定,现在有助于确定患病患者的适当诊断和管理。在本节中,我们描述了主要IBMFS(范可尼贫血、先天性角化不良、施-戴综合征和戴-布综合征)的体格检查和实验室检查结果及管理。我们还讨论了它们对日本患者临床特征的可能影响。